Daniel Schultz, M.D., former director of the Center for Devices and Radiological Health (CDRH) at the U.S. Food and Drug Administration (FDA), has joined Greenleaf Health LLC as senior vice president, medical devices and combination products, according to the Washington, D.C.-based firm.
In this role, Schultz will provide strategic consulting services and work with Greenleaf clients to bring innovative devices to patients at the firm’s newly expanded Washington, D.C. headquarters. Greenleaf Health is a full-service regulatory consulting firm that provides strategic guidance to companies regulated by the FDA.
In addition, Schultz is assistant professor of surgery at the Uniformed Services University of the Health Sciences and a member of the surgical staff at the National Naval Medical Center, both in Bethesda, Md.
Schultz most recently served for 15 years at the FDA as director of CDRH. His career at the agency started in 1994 as a medical officer in the general surgery devices branch of CDRH’s Office of Device Evaluation. In 1995, he was elevated to the position of chief medical officer in the Office of Device Evaluation in the Division of Reproductive, Abdominal, ENT and Radiological Devices.
He, then, served as division director from 1998 to 2001. Schultz became deputy director for clinical and review policy in the Office of Device Evaluation in 2001 and director of the Office of Device Evaluation the next year. He began his role as director of CDRH in 2004.
Prior to joining the FDA, Schultz served as a member of the U.S. Public Health Service.
“Dan Schultz’s distinguished service at FDA, the Public Health Service and as a practicing physician and teacher enables him to bring a unique blend of experience to the Greenleaf team,” said Patrick Ronan, founder and president of Greenleaf Health.